ID   HS104_YEAST             Reviewed;         908 AA.
AC   P31539; D6VXX8;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   28-JAN-2026, entry version 214.
DE   RecName: Full=Heat shock protein 104;
DE   AltName: Full=Protein aggregation-remodeling factor HSP104;
GN   Name=HSP104; OrderedLocusNames=YLL026W; ORFNames=L0948;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND MUTAGENESIS OF LYS-218 AND LYS-620.
RC   STRAIN=ATCC 26109 / X2180 / NCYC 826;
RX   PubMed=1896074; DOI=10.1038/353270a0;
RA   Parsell D.A., Sanchez Y., Stitzel J.D., Lindquist S.L.;
RT   "Hsp104 is a highly conserved protein with two essential nucleotide-binding
RT   sites.";
RL   Nature 353:270-273(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169871; DOI=10.1038/387s087;
RA   Johnston M., Hillier L.W., Riles L., Albermann K., Andre B., Ansorge W.,
RA   Benes V., Brueckner M., Delius H., Dubois E., Duesterhoeft A.,
RA   Entian K.-D., Floeth M., Goffeau A., Hebling U., Heumann K.,
RA   Heuss-Neitzel D., Hilbert H., Hilger F., Kleine K., Koetter P., Louis E.J.,
RA   Messenguy F., Mewes H.-W., Miosga T., Moestl D., Mueller-Auer S.,
RA   Nentwich U., Obermaier B., Piravandi E., Pohl T.M., Portetelle D.,
RA   Purnelle B., Rechmann S., Rieger M., Rinke M., Rose M., Scharfe M.,
RA   Scherens B., Scholler P., Schwager C., Schwarz S., Underwood A.P.,
RA   Urrestarazu L.A., Vandenbol M., Verhasselt P., Vierendeels F., Voet M.,
RA   Volckaert G., Voss H., Wambutt R., Wedler E., Wedler H., Zimmermann F.K.,
RA   Zollner A., Hani J., Hoheisel J.D.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XII.";
RL   Nature 387:87-90(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J.,
RA   Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J.,
RA   Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D.,
RA   LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-encoding
RT   clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 749-908.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9046100;
RX   DOI=10.1002/(sici)1097-0061(199702)13:2<183::aid-yea65>3.0.co;2-v;
RA   Purnelle B., Goffeau A.;
RT   "The sequence of 32kb on the left arm of yeast chromosome XII reveals six
RT   known genes, a new member of the seripauperins family and a new ABC
RT   transporter homologous to the human multidrug resistance protein.";
RL   Yeast 13:183-188(1997).
RN   [6]
RP   FUNCTION.
RX   PubMed=2188365; DOI=10.1126/science.2188365;
RA   Sanchez Y., Lindquist S.L.;
RT   "HSP104 required for induced thermotolerance.";
RL   Science 248:1112-1115(1990).
RN   [7]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=1600951; DOI=10.1002/j.1460-2075.1992.tb05295.x;
RA   Sanchez Y., Taulien J., Borkovich K.A., Lindquist S.L.;
RT   "Hsp104 is required for tolerance to many forms of stress.";
RL   EMBO J. 11:2357-2364(1992).
RN   [8]
RP   FUNCTION.
RX   PubMed=8407824; DOI=10.1128/jb.175.20.6484-6491.1993;
RA   Sanchez Y., Parsell D.A., Taulien J., Vogel J.L., Craig E.A.,
RA   Lindquist S.L.;
RT   "Genetic evidence for a functional relationship between Hsp104 and Hsp70.";
RL   J. Bacteriol. 175:6484-6491(1993).
RN   [9]
RP   INDUCTION, MUTAGENESIS OF LYS-218 AND LYS-620, SUBUNIT, AND ELECTRON
RP   MICROSCOPY.
RX   PubMed=8308017; DOI=10.1016/s0021-9258(17)41804-7;
RA   Parsell D.A., Kowal A.S., Lindquist S.L.;
RT   "Saccharomyces cerevisiae Hsp104 protein. Purification and characterization
RT   of ATP-induced structural changes.";
RL   J. Biol. Chem. 269:4480-4487(1994).
RN   [10]
RP   FUNCTION.
RX   PubMed=7984243; DOI=10.1038/372475a0;
RA   Parsell D.A., Kowal A.S., Singer M.A., Lindquist S.L.;
RT   "Protein disaggregation mediated by heat-shock protein Hsp104.";
RL   Nature 372:475-478(1994).
RN   [11]
RP   FUNCTION IN PRION MAINTENANCE.
RX   PubMed=7754373; DOI=10.1126/science.7754373;
RA   Chernoff Y.O., Lindquist S.L., Ono B., Inge-Vechtomov S.G., Liebman S.W.;
RT   "Role of the chaperone protein Hsp104 in propagation of the yeast prion-
RT   like factor [psi+].";
RL   Science 268:880-884(1995).
RN   [12]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=8643570; DOI=10.1073/pnas.93.11.5301;
RA   Lindquist S.L., Kim G.;
RT   "Heat-shock protein 104 expression is sufficient for thermotolerance in
RT   yeast.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:5301-5306(1996).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9703962; DOI=10.1006/bbrc.1998.9008;
RA   Fujita K., Kawai R., Iwahashi H., Komatsu Y.;
RT   "Hsp104 responds to heat and oxidative stress with different intracellular
RT   localization in Saccharomyces cerevisiae.";
RL   Biochem. Biophys. Res. Commun. 248:542-547(1998).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH YDJ1.
RX   PubMed=9674429; DOI=10.1016/s0092-8674(00)81223-4;
RA   Glover J.R., Lindquist S.L.;
RT   "Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously
RT   aggregated proteins.";
RL   Cell 94:73-82(1998).
RN   [15]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF GLY-217; LYS-218; GLY-619
RP   AND LYS-620.
RX   PubMed=9624144; DOI=10.1074/jbc.273.25.15546;
RA   Schirmer E.C., Queitsch C., Kowal A.S., Parsell D.A., Lindquist S.L.;
RT   "The ATPase activity of Hsp104, effects of environmental conditions and
RT   mutations.";
RL   J. Biol. Chem. 273:15546-15552(1998).
RN   [16]
RP   ERRATUM OF PUBMED:9624144.
RA   Schirmer E.C., Queitsch C., Kowal A.S., Parsell D.A., Lindquist S.L.;
RL   J. Biol. Chem. 273:19922-19922(1998).
RN   [17]
RP   FUNCTION, SUBUNIT, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9534180; DOI=10.1016/s0076-6879(98)90036-2;
RA   Schirmer E.C., Lindquist S.L.;
RT   "Purification and properties of Hsp104 from yeast.";
RL   Methods Enzymol. 290:430-444(1998).
RN   [18]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10467108; DOI=10.1054/csac.1999.0076;
RA   Kawai R., Fujita K., Iwahashi H., Komatsu Y.;
RT   "Direct evidence for the intracellular localization of Hsp104 in
RT   Saccharomyces cerevisiae by immunoelectron microscopy.";
RL   Cell Stress Chaperones 4:46-53(1999).
RN   [19]
RP   FUNCTION IN PRION PROPAGATION.
RX   PubMed=10678178; DOI=10.1016/s1097-2765(00)80412-8;
RA   Sondheimer N., Lindquist S.L.;
RT   "Rnq1: an epigenetic modifier of protein function in yeast.";
RL   Mol. Cell 5:163-172(2000).
RN   [20]
RP   FUNCTION IN PRION PROPAGATION.
RX   PubMed=11073991; DOI=10.1128/mcb.20.23.8916-8922.2000;
RA   Moriyama H., Edskes H.K., Wickner R.B.;
RT   "[URE3] prion propagation in Saccharomyces cerevisiae: requirement for
RT   chaperone Hsp104 and curing by overexpressed chaperone Ydj1p.";
RL   Mol. Cell. Biol. 20:8916-8922(2000).
RN   [21]
RP   FUNCTION IN PRION PROPAGATION.
RX   PubMed=11375656; DOI=10.1007/s002840010251;
RA   Jung G., Masison D.C.;
RT   "Guanidine hydrochloride inhibits Hsp104 activity in vivo: a possible
RT   explanation for its effect in curing yeast prions.";
RL   Curr. Microbiol. 43:7-10(2001).
RN   [22]
RP   INTERACTION WITH CNS1; CPR7 AND STI1.
RX   PubMed=11604493; DOI=10.1128/mcb.21.22.7569-7575.2001;
RA   Abbas-Terki T., Donze O., Briand P.-A., Picard D.;
RT   "Hsp104 interacts with Hsp90 cochaperones in respiring yeast.";
RL   Mol. Cell. Biol. 21:7569-7575(2001).
RN   [23]
RP   FUNCTION IN PRION PROPAGATION, AND MUTAGENESIS OF LYS-218 AND LYS-620.
RX   PubMed=11442834; DOI=10.1046/j.1365-2958.2001.02478.x;
RA   Ferreira P.C., Ness F., Edwards S.R., Cox B.S., Tuite M.F.;
RT   "The elimination of the yeast [PSI+] prion by guanidine hydrochloride is
RT   the result of Hsp104 inactivation.";
RL   Mol. Microbiol. 40:1357-1369(2001).
RN   [24]
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND MUTAGENESIS OF GLY-217;
RP   LYS-218; GLY-619; LYS-620 AND THR-621.
RX   PubMed=11158570; DOI=10.1073/pnas.98.3.914;
RA   Schirmer E.C., Ware D.M., Queitsch C., Kowal A.S., Lindquist S.L.;
RT   "Subunit interactions influence the biochemical and biological properties
RT   of Hsp104.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:914-919(2001).
RN   [25]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF THR-317 AND ASN-728.
RX   PubMed=11782421; DOI=10.1093/emboj/21.1.12;
RA   Hattendorf D.A., Lindquist S.L.;
RT   "Cooperative kinetics of both Hsp104 ATPase domains and interdomain
RT   communication revealed by AAA sensor-1 mutants.";
RL   EMBO J. 21:12-21(2002).
RN   [26]
RP   SUBSTRATE-BINDING, AND MUTAGENESIS OF LYS-218; ALA-315; ALA-503 AND
RP   ASN-728.
RX   PubMed=11983167; DOI=10.1016/s1097-2765(02)00499-9;
RA   Cashikar A.G., Schirmer E.C., Hattendorf D.A., Glover J.R.,
RA   Ramakrishnan M.S., Ware D.M., Lindquist S.L.;
RT   "Defining a pathway of communication from the C-terminal peptide binding
RT   domain to the N-terminal ATPase domain in a AAA protein.";
RL   Mol. Cell 9:751-760(2002).
RN   [27]
RP   FUNCTION IN PRION PROPAGATION, AND MUTAGENESIS OF LYS-218 AND LYS-620.
RX   PubMed=12101251; DOI=10.1128/mcb.22.15.5593-5605.2002;
RA   Ness F., Ferreira P.C., Cox B.S., Tuite M.F.;
RT   "Guanidine hydrochloride inhibits the generation of prion 'seeds' but not
RT   prion protein aggregation in yeast.";
RL   Mol. Cell. Biol. 22:5593-5605(2002).
RN   [28]
RP   INDUCTION.
RX   PubMed=11967066; DOI=10.1046/j.1365-2958.2002.02860.x;
RA   Grably M.R., Stanhill A., Tell O., Engelberg D.;
RT   "HSF and Msn2/4p can exclusively or cooperatively activate the yeast HSP104
RT   gene.";
RL   Mol. Microbiol. 44:21-35(2002).
RN   [29]
RP   MUTAGENESIS OF TYR-819 AND ARG-826, AND ATP-BINDING.
RX   PubMed=11867765; DOI=10.1073/pnas.261693199;
RA   Hattendorf D.A., Lindquist S.L.;
RT   "Analysis of the AAA sensor-2 motif in the C-terminal ATPase domain of
RT   Hsp104 with a site-specific fluorescent probe of nucleotide binding.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:2732-2737(2002).
RN   [30]
RP   MUTAGENESIS OF ASP-184.
RX   PubMed=12105276; DOI=10.1073/pnas.152333299;
RA   Jung G., Jones G., Masison D.C.;
RT   "Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion-
RT   curing by guanidine, prion propagation, and thermotolerance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:9936-9941(2002).
RN   [31]
RP   FUNCTION IN PRION FRAGMENTATION.
RX   PubMed=14507919; DOI=10.1074/jbc.m307996200;
RA   Kryndushkin D.S., Alexandrov I.M., Ter-Avanesyan M.D., Kushnirov V.V.;
RT   "Yeast [PSI+] prion aggregates are formed by small Sup35 polymers
RT   fragmented by Hsp104.";
RL   J. Biol. Chem. 278:49636-49643(2003).
RN   [32]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [33]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [34]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-620, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=14557538; DOI=10.1073/pnas.2135500100;
RA   Hitchcock A.L., Auld K., Gygi S.P., Silver P.A.;
RT   "A subset of membrane-associated proteins is ubiquitinated in response to
RT   mutations in the endoplasmic reticulum degradation machinery.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12735-12740(2003).
RN   [35]
RP   ACTIVITY REGULATION.
RX   PubMed=14668331; DOI=10.1074/jbc.m312403200;
RA   Grimminger V., Richter K., Imhof A., Buchner J., Walter S.;
RT   "The prion curing agent guanidinium chloride specifically inhibits ATP
RT   hydrolysis by Hsp104.";
RL   J. Biol. Chem. 279:7378-7383(2004).
RN   [36]
RP   FUNCTION, MUTAGENESIS OF TYR-257; GLU-645 AND TYR-662, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15128736; DOI=10.1074/jbc.m403777200;
RA   Lum R., Tkach J.M., Vierling E., Glover J.R.;
RT   "Evidence for an unfolding/threading mechanism for protein disaggregation
RT   by Saccharomyces cerevisiae Hsp104.";
RL   J. Biol. Chem. 279:29139-29146(2004).
RN   [37]
RP   MUTAGENESIS OF GLY-217; THR-499; ALA-503 AND ALA-509.
RX   PubMed=14978213; DOI=10.1091/mbc.e02-08-0502;
RA   Schirmer E.C., Homann O.R., Kowal A.S., Lindquist S.L.;
RT   "Dominant gain-of-function mutations in Hsp104p reveal crucial roles for
RT   the middle region.";
RL   Mol. Biol. Cell 15:2061-2072(2004).
RN   [38]
RP   INDUCTION.
RX   PubMed=15049822; DOI=10.1111/j.1365-2958.2003.03959.x;
RA   Seppae L., Haenninen A.-L., Makarow M.;
RT   "Upregulation of the Hsp104 chaperone at physiological temperature during
RT   recovery from thermal insult.";
RL   Mol. Microbiol. 52:217-225(2004).
RN   [39]
RP   FUNCTION IN PRION PROPAGATION.
RX   PubMed=15155912; DOI=10.1126/science.1098007;
RA   Shorter J., Lindquist S.L.;
RT   "Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion
RT   conformers.";
RL   Science 304:1793-1797(2004).
RN   [40]
RP   FUNCTION.
RX   PubMed=15843375; DOI=10.1074/jbc.m502697200;
RA   Haslbeck M., Miess A., Stromer T., Walter S., Buchner J.;
RT   "Disassembling protein aggregates in the yeast cytosol. The cooperation of
RT   Hsp26 with Ssa1 and Hsp104.";
RL   J. Biol. Chem. 280:23861-23868(2005).
RN   [41]
RP   FUNCTION.
RX   PubMed=15845535; DOI=10.1074/jbc.m502854200;
RA   Cashikar A.G., Duennwald M., Lindquist S.L.;
RT   "A chaperone pathway in protein disaggregation. Hsp26 alters the nature of
RT   protein aggregates to facilitate reactivation by Hsp104.";
RL   J. Biol. Chem. 280:23869-23875(2005).
RN   [42]
RP   ERRATUM OF PUBMED:15845535.
RA   Cashikar A.G., Duennwald M., Lindquist S.L.;
RL   J. Biol. Chem. 281:8996-8996(2006).
RN   [43]
RP   SUBUNIT, AND MUTAGENESIS OF LYS-218; GLU-285; LYS-620 AND GLU-687.
RX   PubMed=16135516; DOI=10.1074/jbc.m506149200;
RA   Boesl B., Grimminger V., Walter S.;
RT   "Substrate binding to the molecular chaperone Hsp104 and its regulation by
RT   nucleotides.";
RL   J. Biol. Chem. 280:38170-38176(2005).
RN   [44]
RP   FUNCTION IN PRION DISASSEMBLY.
RX   PubMed=16570324; DOI=10.1002/cbic.200500382;
RA   Narayanan S., Walter S., Reif B.;
RT   "Yeast prion-protein, sup35, fibril formation proceeds by addition and
RT   substraction of oligomers.";
RL   ChemBioChem 7:757-765(2006).
RN   [45]
RP   FUNCTION IN PRION DISASSEMBLY.
RX   PubMed=16885031; DOI=10.1016/j.molcel.2006.05.042;
RA   Shorter J., Lindquist S.L.;
RT   "Destruction or potentiation of different prions catalyzed by similar
RT   Hsp104 remodeling activities.";
RL   Mol. Cell 23:425-438(2006).
RN   [46]
RP   SUBUNIT, ELECTRON MICROSCOPY, AND MUTAGENESIS OF ARG-334; ARG-419; ARG-444;
RP   ARG-495; ASN-728 AND ARG-765.
RX   PubMed=18160044; DOI=10.1016/j.cell.2007.10.047;
RA   Wendler P., Shorter J., Plisson C., Cashikar A.G., Lindquist S.L.,
RA   Saibil H.R.;
RT   "Atypical AAA+ subunit packing creates an expanded cavity for
RT   disaggregation by the protein-remodeling factor Hsp104.";
RL   Cell 131:1366-1377(2007).
RN   [47]
RP   FUNCTION, AND MUTAGENESIS OF LYS-218; GLU-285; LYS-620 AND GLU-687.
RX   PubMed=17543332; DOI=10.1016/j.jmb.2007.04.070;
RA   Schaupp A., Marcinowski M., Grimminger V., Boesl B., Walter S.;
RT   "Processing of proteins by the molecular chaperone Hsp104.";
RL   J. Mol. Biol. 370:674-686(2007).
RN   [48]
RP   FUNCTION IN PRION PROPAGATION, AND MUTAGENESIS OF LEU-462; PRO-557 AND
RP   ASP-704.
RX   PubMed=17367387; DOI=10.1111/j.1365-2958.2007.05629.x;
RA   Kurahashi H., Nakamura Y.;
RT   "Channel mutations in Hsp104 hexamer distinctively affect thermotolerance
RT   and prion-specific propagation.";
RL   Mol. Microbiol. 63:1669-1683(2007).
RN   [49]
RP   FUNCTION, AND MUTAGENESIS OF LYS-218; THR-317; LYS-620 AND ASN-728.
RX   PubMed=17259993; DOI=10.1038/nsmb1198;
RA   Doyle S.M., Shorter J., Zolkiewski M., Hoskins J.R., Lindquist S.L.,
RA   Wickner S.;
RT   "Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes
RT   protein-remodeling activity.";
RL   Nat. Struct. Mol. Biol. 14:114-122(2007).
RN   [50]
RP   FUNCTION IN PRION PROPAGATION.
RX   PubMed=17253904; DOI=10.1371/journal.pbio.0050024;
RA   Satpute-Krishnan P., Langseth S.X., Serio T.R.;
RT   "Hsp104-dependent remodeling of prion complexes mediates protein-only
RT   inheritance.";
RL   PLoS Biol. 5:251-262(2007).
RN   [51]
RP   INTERACTION WITH CPR7.
RX   PubMed=18197703; DOI=10.1021/bi701714s;
RA   Mackay R.G., Helsen C.W., Tkach J.M., Glover J.R.;
RT   "The C-terminal extension of Saccharomyces cerevisiae Hsp104 plays a role
RT   in oligomer assembly.";
RL   Biochemistry 47:1918-1927(2008).
RN   [52]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206; SER-306; THR-499 AND
RP   SER-535, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [53]
RP   FUNCTION.
RX   PubMed=18312264; DOI=10.1111/j.1365-2958.2008.06135.x;
RA   Tessarz P., Mogk A., Bukau B.;
RT   "Substrate threading through the central pore of the Hsp104 chaperone as a
RT   common mechanism for protein disaggregation and prion propagation.";
RL   Mol. Microbiol. 68:87-97(2008).
RN   [54]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18756251; DOI=10.1038/nature07195;
RA   Kaganovich D., Kopito R., Frydman J.;
RT   "Misfolded proteins partition between two distinct quality control
RT   compartments.";
RL   Nature 454:1088-1095(2008).
RN   [55]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-778; LYS-782 AND LYS-789.
RX   PubMed=17973656; DOI=10.1111/j.1600-0854.2007.00666.x;
RA   Tkach J.M., Glover J.R.;
RT   "Nucleocytoplasmic trafficking of the molecular chaperone Hsp104 in
RT   unstressed and heat-shocked cells.";
RL   Traffic 9:39-56(2008).
RN   [56]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides insights
RT   into evolution.";
RL   Science 325:1682-1686(2009).
RN   [57]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [58]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-442, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22106047; DOI=10.1002/pmic.201100166;
RA   Starita L.M., Lo R.S., Eng J.K., von Haller P.D., Fields S.;
RT   "Sites of ubiquitin attachment in Saccharomyces cerevisiae.";
RL   Proteomics 12:236-240(2012).
CC   -!- FUNCTION: Required, in concert with Hsp40 (YDJ1) and Hsp70 (SSA1) and
CC       small Hsps (HSP26), for the dissociation, resolubilization and
CC       refolding of aggregates of damaged proteins after heat or other
CC       environmental stresses. Extracts proteins from aggregates by unfolding
CC       and threading them in an ATP-dependent process through the axial
CC       channel of the protein hexamer, after which they can be refolded by
CC       components of the Hsp70/Hsp40 chaperone system. Substrate binding is
CC       ATP-dependent, and release of bound polypeptide is triggered by ATP
CC       hydrolysis. Also responsible for the maintenance of prions by
CC       dissociating prion fibrils into smaller oligomers, thereby producing
CC       transmissible seeds that can infect daughter cells during mitosis and
CC       meiosis. Loss of HSP104 can cure yeast cells of the prions [PSI+],
CC       [URE3] and [PIN+]. Excess HSP104 can also specifically cure cells of
CC       [PSI+]. {ECO:0000269|PubMed:10678178, ECO:0000269|PubMed:11073991,
CC       ECO:0000269|PubMed:11375656, ECO:0000269|PubMed:11442834,
CC       ECO:0000269|PubMed:12101251, ECO:0000269|PubMed:14507919,
CC       ECO:0000269|PubMed:15128736, ECO:0000269|PubMed:15155912,
CC       ECO:0000269|PubMed:15843375, ECO:0000269|PubMed:15845535,
CC       ECO:0000269|PubMed:1600951, ECO:0000269|PubMed:16570324,
CC       ECO:0000269|PubMed:16885031, ECO:0000269|PubMed:17253904,
CC       ECO:0000269|PubMed:17259993, ECO:0000269|PubMed:17367387,
CC       ECO:0000269|PubMed:17543332, ECO:0000269|PubMed:18312264,
CC       ECO:0000269|PubMed:2188365, ECO:0000269|PubMed:7754373,
CC       ECO:0000269|PubMed:7984243, ECO:0000269|PubMed:8407824,
CC       ECO:0000269|PubMed:8643570, ECO:0000269|PubMed:9534180,
CC       ECO:0000269|PubMed:9674429}.
CC   -!- ACTIVITY REGULATION: Inhibited by micromolar concentrations of
CC       guanidinium chloride. Inhibits the ATPase activity, but does not
CC       dissociate the hexameric protein. {ECO:0000269|PubMed:14668331}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=170 uM for ATP (at NBD1) {ECO:0000269|PubMed:11158570,
CC         ECO:0000269|PubMed:11782421, ECO:0000269|PubMed:15128736,
CC         ECO:0000269|PubMed:9534180, ECO:0000269|PubMed:9624144};
CC         KM=4.7 uM for ATP (at NBD2) {ECO:0000269|PubMed:11158570,
CC         ECO:0000269|PubMed:11782421, ECO:0000269|PubMed:15128736,
CC         ECO:0000269|PubMed:9534180, ECO:0000269|PubMed:9624144};
CC         Vmax=1.25 nmol/min/ug enzyme for ATP {ECO:0000269|PubMed:11158570,
CC         ECO:0000269|PubMed:11782421, ECO:0000269|PubMed:15128736,
CC         ECO:0000269|PubMed:9534180, ECO:0000269|PubMed:9624144};
CC   -!- SUBUNIT: Homohexamer, forming a ring with a central pore. The hexamer
CC       is stabilized by high protein concentrations and by ADP or ATP.
CC       Oligomerization influences ATP hydrolysis activity at NBD2. Interacts
CC       with YDJ1. Interacts (via C-terminal DDLD tetrapeptide) with CNS1, CPR7
CC       and STI1 (via TPR repeats); under respiratory growth conditions.
CC       {ECO:0000269|PubMed:11158570, ECO:0000269|PubMed:11604493,
CC       ECO:0000269|PubMed:16135516, ECO:0000269|PubMed:18160044,
CC       ECO:0000269|PubMed:18197703, ECO:0000269|PubMed:8308017,
CC       ECO:0000269|PubMed:9534180, ECO:0000269|PubMed:9674429}.
CC   -!- INTERACTION:
CC       P31539; P43583: BLM10; NbExp=2; IntAct=EBI-8050, EBI-22761;
CC       P31539; P53959: COG6; NbExp=2; IntAct=EBI-8050, EBI-4829;
CC       P31539; P53691: CPR6; NbExp=5; IntAct=EBI-8050, EBI-5429;
CC       P31539; P38241: ECM2; NbExp=2; IntAct=EBI-8050, EBI-780;
CC       P31539; P40566: EGH1; NbExp=2; IntAct=EBI-8050, EBI-3657860;
CC       P31539; Q12178: FCY1; NbExp=2; IntAct=EBI-8050, EBI-6851;
CC       P31539; Q08109: HRD1; NbExp=2; IntAct=EBI-8050, EBI-37613;
CC       P31539; P31539: HSP104; NbExp=3; IntAct=EBI-8050, EBI-8050;
CC       P31539; Q08001: LAM6; NbExp=2; IntAct=EBI-8050, EBI-30998;
CC       P31539; P49367: LYS4; NbExp=3; IntAct=EBI-8050, EBI-10276;
CC       P31539; Q12285: MDY2; NbExp=2; IntAct=EBI-8050, EBI-34904;
CC       P31539; P53165: SGF73; NbExp=3; IntAct=EBI-8050, EBI-23812;
CC       P31539; P32585: SRB5; NbExp=2; IntAct=EBI-8050, EBI-18032;
CC       P31539; P52917: VPS4; NbExp=2; IntAct=EBI-8050, EBI-20475;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Shuttles between the
CC       cytoplasm and the nucleus in an importin KAP95- and KAP121-dependent
CC       and an exportin XPO1-dependent manner. Accumulation in the nucleus is
CC       enhanced by severe heat shock. In the cytoplasm, concentrates on a
CC       perivacuolar compartment, the 'insoluble protein deposit' (IPOD), in
CC       which terminally aggregated proteins are sequestered. It is also found,
CC       to a lesser extent, at a 'juxtanuclear quality control' (JUNQ)
CC       compartment, where soluble ubiquitinated misfolded proteins accumulate.
CC   -!- INDUCTION: By heat stress dependent on the heat shock transcription
CC       factor HSF1 and the general stress transcription factors MSN2 and MSN4.
CC       Expressed at a higher level in respiring cells than in fermenting
CC       cells. Expressed in stationary phase cells and spores (at protein
CC       level). {ECO:0000269|PubMed:11967066, ECO:0000269|PubMed:15049822,
CC       ECO:0000269|PubMed:1600951, ECO:0000269|PubMed:8308017,
CC       ECO:0000269|PubMed:8643570}.
CC   -!- DOMAIN: Has 2 AAA ATPase type nucleotide-binding domains (NBDs) per
CC       monomer, a low-affinity, high-turnover site (NBD1) and a high-affinity
CC       site (NBD2) with a 300-fold slower rate of hydrolysis. There is
CC       allosteric regulation between the 2 sites. ATP binding to NBD1 triggers
CC       binding of polypeptides and stimulates ATP hydrolysis at NBD2.
CC       Nucleotide binding to NBD2 is crucial for oligomerization.
CC   -!- DOMAIN: The C-terminal extension is involved in oligomerization.
CC   -!- MISCELLANEOUS: Present with 32800 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the ClpA/ClpB family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M67479; AAA50477.1; -; Genomic_DNA.
DR   EMBL; Z73131; CAA97475.1; -; Genomic_DNA.
DR   EMBL; Z73130; CAA97474.1; -; Genomic_DNA.
DR   EMBL; AY693002; AAT93021.1; -; Genomic_DNA.
DR   EMBL; X97560; CAA66164.1; -; Genomic_DNA.
DR   EMBL; BK006945; DAA09294.1; -; Genomic_DNA.
DR   PIR; S61476; S61476.
DR   RefSeq; NP_013074.1; NM_001181846.1.
DR   PDB; 5KNE; EM; 5.64 A; A/B/C/D/E/F=6-857.
DR   PDB; 5U2U; X-ray; 2.54 A; A/B/C=1-166.
DR   PDB; 5VJH; EM; 4.00 A; A/B/C/D/E/F=1-908.
DR   PDB; 5VY8; EM; 4.00 A; A/B/C/D/E/F=1-908.
DR   PDB; 5VY9; EM; 4.00 A; A/B/C/D/E/F=1-908.
DR   PDB; 5VYA; EM; 4.00 A; A/B/C/D/E/F=1-908.
DR   PDB; 5WBW; X-ray; 2.60 A; A/B/D=4-356.
DR   PDB; 6AHF; EM; 6.78 A; A/B/C/D/E/F=1-908.
DR   PDB; 6AMN; X-ray; 2.82 A; A=4-352.
DR   PDB; 6N8T; EM; 7.70 A; A/B/C/D/E/F=6-884.
DR   PDB; 6N8V; EM; 5.64 A; A/B/C/D/E/F=6-884.
DR   PDB; 6N8Z; EM; 9.30 A; A/B/C/D/E/F=6-884.
DR   PDBsum; 5KNE; -.
DR   PDBsum; 5U2U; -.
DR   PDBsum; 5VJH; -.
DR   PDBsum; 5VY8; -.
DR   PDBsum; 5VY9; -.
DR   PDBsum; 5VYA; -.
DR   PDBsum; 5WBW; -.
DR   PDBsum; 6AHF; -.
DR   PDBsum; 6AMN; -.
DR   PDBsum; 6N8T; -.
DR   PDBsum; 6N8V; -.
DR   PDBsum; 6N8Z; -.
DR   AlphaFoldDB; P31539; -.
DR   EMDB; EMD-0375; -.
DR   EMDB; EMD-0376; -.
DR   EMDB; EMD-0377; -.
DR   EMDB; EMD-8267; -.
DR   EMDB; EMD-8697; -.
DR   EMDB; EMD-8744; -.
DR   EMDB; EMD-8745; -.
DR   EMDB; EMD-8746; -.
DR   EMDB; EMD-9625; -.
DR   SMR; P31539; -.
DR   BioGRID; 31226; 709.
DR   ComplexPortal; CPX-1861; GET4-GET5 transmembrane domain recognition complex.
DR   DIP; DIP-2252N; -.
DR   FunCoup; P31539; 655.
DR   IntAct; P31539; 426.
DR   MINT; P31539; -.
DR   STRING; 4932.YLL026W; -.
DR   CarbonylDB; P31539; -.
DR   GlyGen; P31539; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; P31539; -.
DR   PaxDb; 4932-YLL026W; -.
DR   PeptideAtlas; P31539; -.
DR   EnsemblFungi; YLL026W_mRNA; YLL026W; YLL026W.
DR   GeneID; 850633; -.
DR   KEGG; sce:YLL026W; -.
DR   AGR; SGD:S000003949; -.
DR   SGD; S000003949; HSP104.
DR   VEuPathDB; FungiDB:YLL026W; -.
DR   eggNOG; KOG1051; Eukaryota.
DR   HOGENOM; CLU_005070_4_0_1; -.
DR   InParanoid; P31539; -.
DR   OMA; ERMKAVM; -.
DR   OrthoDB; 47330at2759; -.
DR   BioCyc; YEAST:G3O-32130-MONOMER; -.
DR   SABIO-RK; P31539; -.
DR   BioGRID-ORCS; 850633; 0 hits in 10 CRISPR screens.
DR   CD-CODE; 67785C55; Hypersomatic shock foci.
DR   CD-CODE; 9B47C524; Peri-nucleolar condensate.
DR   CD-CODE; BA10A4D8; Htt inclusion.
DR   CD-CODE; E03F929F; Stress granule.
DR   PRO; PR:P31539; -.
DR   Proteomes; UP000002311; Chromosome XII.
DR   RNAct; P31539; protein.
DR   GO; GO:0005737; C:cytoplasm; IDA:SGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0034399; C:nuclear periphery; IDA:SGD.
DR   GO; GO:0005634; C:nucleus; IDA:SGD.
DR   GO; GO:0072380; C:TRC complex; IDA:SGD.
DR   GO; GO:0043531; F:ADP binding; IMP:SGD.
DR   GO; GO:0005524; F:ATP binding; IMP:SGD.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:SGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IDA:SGD.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:SGD.
DR   GO; GO:0070370; P:cellular heat acclimation; IMP:SGD.
DR   GO; GO:0034605; P:cellular response to heat; IDA:SGD.
DR   GO; GO:0006620; P:post-translational protein targeting to endoplasmic reticulum membrane; NAS:ComplexPortal.
DR   GO; GO:0006457; P:protein folding; IDA:SGD.
DR   GO; GO:0034975; P:protein folding in endoplasmic reticulum; IMP:SGD.
DR   GO; GO:0042026; P:protein refolding; IBA:GO_Central.
DR   GO; GO:0043335; P:protein unfolding; IMP:SGD.
DR   GO; GO:0035617; P:stress granule disassembly; IDA:SGD.
DR   GO; GO:0005991; P:trehalose metabolic process; IMP:SGD.
DR   CDD; cd00009; AAA; 1.
DR   CDD; cd19499; RecA-like_ClpB_Hsp104-like; 1.
DR   FunFam; 1.10.1780.10:FF:000003; ATP-dependent chaperone ClpB; 1.
DR   FunFam; 1.10.8.60:FF:000017; ATP-dependent chaperone ClpB; 1.
DR   FunFam; 3.40.50.300:FF:000120; ATP-dependent chaperone ClpB; 1.
DR   FunFam; 3.40.50.300:FF:000025; ATP-dependent Clp protease subunit; 1.
DR   FunFam; 3.40.50.300:FF:000010; Chaperone clpB 1, putative; 1.
DR   Gene3D; 1.10.8.60; -; 1.
DR   Gene3D; 1.10.1780.10; Clp, N-terminal domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 3.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR019489; Clp_ATPase_C.
DR   InterPro; IPR036628; Clp_N_dom_sf.
DR   InterPro; IPR004176; Clp_R_N.
DR   InterPro; IPR001270; ClpA/B.
DR   InterPro; IPR018368; ClpA/B_CS1.
DR   InterPro; IPR028299; ClpA/B_CS2.
DR   InterPro; IPR041546; ClpA/ClpB_AAA_lid.
DR   InterPro; IPR050130; ClpA_ClpB.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11638; ATP-DEPENDENT CLP PROTEASE; 1.
DR   PANTHER; PTHR11638:SF18; HEAT SHOCK PROTEIN 104; 1.
DR   Pfam; PF00004; AAA; 1.
DR   Pfam; PF07724; AAA_2; 1.
DR   Pfam; PF17871; AAA_lid_9; 1.
DR   Pfam; PF02861; Clp_N; 1.
DR   Pfam; PF10431; ClpB_D2-small; 1.
DR   PRINTS; PR00300; CLPPROTEASEA.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM01086; ClpB_D2-small; 1.
DR   SUPFAM; SSF81923; Double Clp-N motif; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS51903; CLP_R; 1.
DR   PROSITE; PS00870; CLPAB_1; 1.
DR   PROSITE; PS00871; CLPAB_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Chaperone; Coiled coil; Cytoplasm;
KW   Isopeptide bond; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Stress response; Ubl conjugation.
FT   CHAIN           1..908
FT                   /note="Heat shock protein 104"
FT                   /id="PRO_0000191212"
FT   DOMAIN          4..150
FT                   /note="Clp R"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01251"
FT   REGION          7..76
FT                   /note="Repeat 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01251"
FT   REGION          88..150
FT                   /note="Repeat 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01251"
FT   REGION          167..411
FT                   /note="NBD1"
FT   REGION          541..731
FT                   /note="NBD2"
FT   REGION          883..908
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          905..908
FT                   /note="Interaction surface for TPR repeats"
FT   COILED          412..536
FT                   /evidence="ECO:0000255"
FT   MOTIF           773..789
FT                   /note="Nuclear localization signal"
FT   COMPBIAS        892..908
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         212..219
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255"
FT   BINDING         614..621
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         206
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956,
FT                   ECO:0007744|PubMed:19779198"
FT   MOD_RES         306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956"
FT   MOD_RES         499
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18407956"
FT   MOD_RES         535
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956"
FT   CROSSLNK        442
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   CROSSLNK        620
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:14557538"
FT   MUTAGEN         184
FT                   /note="D->A,D,F,N,L,Q,S: Confers resistance to prion-curing
FT                   by guanidine."
FT                   /evidence="ECO:0000269|PubMed:12105276"
FT   MUTAGEN         184
FT                   /note="D->K,W,Y: Impairs prion propagation."
FT                   /evidence="ECO:0000269|PubMed:12105276"
FT   MUTAGEN         217
FT                   /note="G->S: Largely reduces ATP hydrolysis. Alters bud
FT                   morphology and causes septin mislocalization; when
FT                   associated with I-499."
FT                   /evidence="ECO:0000269|PubMed:11158570,
FT                   ECO:0000269|PubMed:14978213, ECO:0000269|PubMed:9624144"
FT   MUTAGEN         217
FT                   /note="G->V: Completely abolishes ATP hydrolysis."
FT                   /evidence="ECO:0000269|PubMed:11158570,
FT                   ECO:0000269|PubMed:14978213, ECO:0000269|PubMed:9624144"
FT   MUTAGEN         218
FT                   /note="K->T: Abolishes substrate binding. Unable to confer
FT                   thermotolerance. Reduces ATP hydrolysis by 98%; when
FT                   associated with T-315. Completely abolishes ATPase
FT                   activity; when associated with T-620."
FT                   /evidence="ECO:0000269|PubMed:11158570,
FT                   ECO:0000269|PubMed:11442834, ECO:0000269|PubMed:11983167,
FT                   ECO:0000269|PubMed:12101251, ECO:0000269|PubMed:16135516,
FT                   ECO:0000269|PubMed:17259993, ECO:0000269|PubMed:17543332,
FT                   ECO:0000269|PubMed:1896074, ECO:0000269|PubMed:8308017,
FT                   ECO:0000269|PubMed:9624144"
FT   MUTAGEN         257
FT                   /note="Y->A: Reduces thermotolerance 10-fold."
FT                   /evidence="ECO:0000269|PubMed:15128736"
FT   MUTAGEN         285
FT                   /note="E->Q: In HSP104(TRAP); completely abolishes ATP
FT                   hydrolysis, but does not affect nucleotide binding, thus
FT                   keeping HSP104 in an ATP-bound state; when associated with
FT                   Q-687."
FT                   /evidence="ECO:0000269|PubMed:16135516,
FT                   ECO:0000269|PubMed:17543332"
FT   MUTAGEN         315
FT                   /note="A->T: Reduces ATP hydrolysis by 98%; when associated
FT                   with T-218."
FT                   /evidence="ECO:0000269|PubMed:11983167"
FT   MUTAGEN         317
FT                   /note="T->A: Reduces rate of ATP hydrolysis at NBD1 nearly
FT                   10-fold. No effect on oligomerization."
FT                   /evidence="ECO:0000269|PubMed:11782421,
FT                   ECO:0000269|PubMed:17259993"
FT   MUTAGEN         334
FT                   /note="R->M: Reduces ATPase activity by 80%. Impairs
FT                   oligomerization."
FT                   /evidence="ECO:0000269|PubMed:18160044"
FT   MUTAGEN         419
FT                   /note="R->M: Reduces ATPase activity by 80%."
FT                   /evidence="ECO:0000269|PubMed:18160044"
FT   MUTAGEN         444
FT                   /note="R->M: Reduces ATPase activity by 80%."
FT                   /evidence="ECO:0000269|PubMed:18160044"
FT   MUTAGEN         462
FT                   /note="L->R: Impairs prion propagation, but does not affect
FT                   thermotolerance."
FT                   /evidence="ECO:0000269|PubMed:17367387"
FT   MUTAGEN         495
FT                   /note="R->M: Increases ATPase activity 3-fold."
FT                   /evidence="ECO:0000269|PubMed:18160044"
FT   MUTAGEN         499
FT                   /note="T->I: Reduces ATP hydrolysis by 50%. Alters bud
FT                   morphology and causes septin mislocalization; when
FT                   associated with S-217."
FT                   /evidence="ECO:0000269|PubMed:14978213"
FT   MUTAGEN         503
FT                   /note="A->V: Increases basal level of ATPase activity and
FT                   abolishes stimulation of ATP hydrolysis upon substrate
FT                   binding. Inhibits growth at 37 degrees Celsius."
FT                   /evidence="ECO:0000269|PubMed:11983167,
FT                   ECO:0000269|PubMed:14978213"
FT   MUTAGEN         509
FT                   /note="A->D: Reduces thermotolerance."
FT                   /evidence="ECO:0000269|PubMed:14978213"
FT   MUTAGEN         557
FT                   /note="P->L: Impairs prion propagation, but does not affect
FT                   thermotolerance."
FT                   /evidence="ECO:0000269|PubMed:17367387"
FT   MUTAGEN         619
FT                   /note="G->V: Impairs oligomerization at low protein
FT                   concentrations."
FT                   /evidence="ECO:0000269|PubMed:11158570,
FT                   ECO:0000269|PubMed:9624144"
FT   MUTAGEN         620
FT                   /note="K->T: Impairs oligomerization at low protein
FT                   concentrations. Reduces ATP hydrolysis rate. Unable to
FT                   confer thermotolerance. Completely abolishes ATPase
FT                   activity; when associated with T-218."
FT                   /evidence="ECO:0000269|PubMed:11158570,
FT                   ECO:0000269|PubMed:11442834, ECO:0000269|PubMed:12101251,
FT                   ECO:0000269|PubMed:16135516, ECO:0000269|PubMed:17259993,
FT                   ECO:0000269|PubMed:17543332, ECO:0000269|PubMed:1896074,
FT                   ECO:0000269|PubMed:8308017, ECO:0000269|PubMed:9624144"
FT   MUTAGEN         621
FT                   /note="T->A: Reduces ATP hydrolysis, but does not affect
FT                   oligomerization."
FT                   /evidence="ECO:0000269|PubMed:11158570"
FT   MUTAGEN         645
FT                   /note="E->K: Abolishes the ability to refold aggregated
FT                   protein in vitro and to provide thermotolerance in vivo."
FT                   /evidence="ECO:0000269|PubMed:15128736"
FT   MUTAGEN         662
FT                   /note="Y->A,K: Abolishes the ability to refold aggregated
FT                   protein in vitro and to provide thermotolerance in vivo."
FT                   /evidence="ECO:0000269|PubMed:15128736"
FT   MUTAGEN         662
FT                   /note="Y->F,W: No effect."
FT                   /evidence="ECO:0000269|PubMed:15128736"
FT   MUTAGEN         687
FT                   /note="E->Q: In HSP104(TRAP); completely abolishes ATP
FT                   hydrolysis, but does not affect nucleotide binding, thus
FT                   keeping HSP104 in an ATP-bound state; when associated with
FT                   Q-285."
FT                   /evidence="ECO:0000269|PubMed:16135516,
FT                   ECO:0000269|PubMed:17543332"
FT   MUTAGEN         704
FT                   /note="D->N: Impairs prion propagation, but does not affect
FT                   thermotolerance."
FT                   /evidence="ECO:0000269|PubMed:17367387"
FT   MUTAGEN         728
FT                   /note="N->A: Almost completely abolishes ATP hydrolysis at
FT                   NBD2, but does not affect nucleotide binding, thus keeping
FT                   NBD2 in an ATP-bound state. Reduces stimulation of ATP
FT                   hydrolysis upon substrate binding."
FT                   /evidence="ECO:0000269|PubMed:11782421,
FT                   ECO:0000269|PubMed:11983167, ECO:0000269|PubMed:17259993,
FT                   ECO:0000269|PubMed:18160044"
FT   MUTAGEN         765
FT                   /note="R->M: Can oligomerize in the absence of
FT                   nucleotides."
FT                   /evidence="ECO:0000269|PubMed:18160044"
FT   MUTAGEN         778
FT                   /note="K->A: In NLS17KA; fails to concentrate in the
FT                   nucleus; when associated with A-782 and A-789."
FT                   /evidence="ECO:0000269|PubMed:17973656"
FT   MUTAGEN         782
FT                   /note="K->A: In NLS17KA; fails to concentrate in the
FT                   nucleus; when associated with A-778 and A-789."
FT                   /evidence="ECO:0000269|PubMed:17973656"
FT   MUTAGEN         789
FT                   /note="K->A: In NLS17KA; fails to concentrate in the
FT                   nucleus; when associated with A-778 and A-782."
FT                   /evidence="ECO:0000269|PubMed:17973656"
FT   MUTAGEN         819
FT                   /note="Y->W: Site-specific fluorescent probe in an
FT                   otherwise Trp-less HSP104. Fluorescence of this Trp changes
FT                   in response to ATP and ADP binding at NBD2. Has no effect
FT                   on ATP hydrolysis or protein stability."
FT                   /evidence="ECO:0000269|PubMed:11867765"
FT   MUTAGEN         826
FT                   /note="R->M: Reduces ATP and ADP binding at NBD2 6-fold,
FT                   but does not affect ATP hydrolysis at NBD2. Reduces
FT                   catalytic rate at NBD1."
FT                   /evidence="ECO:0000269|PubMed:11867765"
FT   HELIX           9..24
FT                   /evidence="ECO:0007829|PDB:5U2U"
FT   STRAND          28..30
FT                   /evidence="ECO:0007829|PDB:5U2U"
FT   HELIX           32..39
FT                   /evidence="ECO:0007829|PDB:5U2U"
FT   HELIX           50..57
FT                   /evidence="ECO:0007829|PDB:5U2U"
FT   HELIX           62..73
FT                   /evidence="ECO:0007829|PDB:5U2U"
FT   HELIX           90..105
FT                   /evidence="ECO:0007829|PDB:5U2U"
FT   STRAND          109..111
FT                   /evidence="ECO:0007829|PDB:5U2U"
FT   HELIX           113..120
FT                   /evidence="ECO:0007829|PDB:5U2U"
FT   HELIX           124..132
FT                   /evidence="ECO:0007829|PDB:5U2U"
FT   HELIX           137..148
FT                   /evidence="ECO:0007829|PDB:5U2U"
FT   HELIX           165..170
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   STRAND          171..173
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           174..179
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           190..200
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   STRAND          203..205
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   STRAND          207..212
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           218..230
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           236..238
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   STRAND          242..246
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           248..252
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           260..273
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   STRAND          279..283
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   TURN            284..286
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           287..290
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           298..306
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   STRAND          311..316
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           318..327
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           330..334
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   STRAND          335..339
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   TURN            344..346
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   HELIX           347..350
FT                   /evidence="ECO:0007829|PDB:5WBW"
FT   TURN            351..355
FT                   /evidence="ECO:0007829|PDB:5WBW"
SQ   SEQUENCE   908 AA;  102035 MW;  4AD0E7E3AF98E318 CRC64;
     MNDQTQFTER ALTILTLAQK LASDHQHPQL QPIHILAAFI ETPEDGSVPY LQNLIEKGRY
     DYDLFKKVVN RNLVRIPQQQ PAPAEITPSY ALGKVLQDAA KIQKQQKDSF IAQDHILFAL
     FNDSSIQQIF KEAQVDIEAI KQQALELRGN TRIDSRGADT NTPLEYLSKY AIDMTEQARQ
     GKLDPVIGRE EEIRSTIRVL ARRIKSNPCL IGEPGIGKTA IIEGVAQRII DDDVPTILQG
     AKLFSLDLAA LTAGAKYKGD FEERFKGVLK EIEESKTLIV LFIDEIHMLM GNGKDDAANI
     LKPALSRGQL KVIGATTNNE YRSIVEKDGA FERRFQKIEV AEPSVRQTVA ILRGLQPKYE
     IHHGVRILDS ALVTAAQLAK RYLPYRRLPD SALDLVDISC AGVAVARDSK PEELDSKERQ
     LQLIQVEIKA LERDEDADST TKDRLKLARQ KEASLQEELE PLRQRYNEEK HGHEELTQAK
     KKLDELENKA LDAERRYDTA TAADLRYFAI PDIKKQIEKL EDQVAEEERR AGANSMIQNV
     VDSDTISETA ARLTGIPVKK LSESENEKLI HMERDLSSEV VGQMDAIKAV SNAVRLSRSG
     LANPRQPASF LFLGLSGSGK TELAKKVAGF LFNDEDMMIR VDCSELSEKY AVSKLLGTTA
     GYVGYDEGGF LTNQLQYKPY SVLLFDEVEK AHPDVLTVML QMLDDGRITS GQGKTIDCSN
     CIVIMTSNLG AEFINSQQGS KIQESTKNLV MGAVRQHFRP EFLNRISSIV IFNKLSRKAI
     HKIVDIRLKE IEERFEQNDK HYKLNLTQEA KDFLAKYGYS DDMGARPLNR LIQNEILNKL
     ALRILKNEIK DKETVNVVLK KGKSRDENVP EEAEECLEVL PNHEATIGAD TLGDDDNEDS
     MEIDDDLD
//
